From a clinical point of view, the f/t PSA% improves the specificity of PCa testing to some extent, whereas it still cannot meet the clinical requirements for precise diagnosis, resulting in considerable unnecessary prostate biopsies. This evidence concerns the gene KLK3 and posterior cortical atrophy.